nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP1A2—Pentoxifylline—systemic scleroderma	0.0876	0.191	CbGbCtD
Maprotiline—CYP1A2—Leflunomide—systemic scleroderma	0.0836	0.182	CbGbCtD
Maprotiline—ABCB1—Lisinopril—systemic scleroderma	0.0766	0.167	CbGbCtD
Maprotiline—ABCB1—Captopril—systemic scleroderma	0.0573	0.125	CbGbCtD
Maprotiline—CYP2D6—Captopril—systemic scleroderma	0.054	0.118	CbGbCtD
Maprotiline—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0451	0.0985	CbGbCtD
Maprotiline—ABCB1—Prednisone—systemic scleroderma	0.0361	0.0787	CbGbCtD
Maprotiline—ABCB1—Methotrexate—systemic scleroderma	0.0181	0.0395	CbGbCtD
Maprotiline—HTR7—myenteric nerve plexus—systemic scleroderma	0.0176	0.17	CbGeAlD
Maprotiline—HTR7—pulmonary artery—systemic scleroderma	0.0125	0.12	CbGeAlD
Maprotiline—HTR2A—myenteric nerve plexus—systemic scleroderma	0.011	0.106	CbGeAlD
Maprotiline—HTR2A—pulmonary artery—systemic scleroderma	0.00777	0.075	CbGeAlD
Maprotiline—HTR7—artery—systemic scleroderma	0.00462	0.0446	CbGeAlD
Maprotiline—HTR7—endothelium—systemic scleroderma	0.0039	0.0377	CbGeAlD
Maprotiline—HTR7—blood vessel—systemic scleroderma	0.0036	0.0347	CbGeAlD
Maprotiline—CHRM5—skin of body—systemic scleroderma	0.00313	0.0302	CbGeAlD
Maprotiline—HTR2A—artery—systemic scleroderma	0.00288	0.0278	CbGeAlD
Maprotiline—HTR2A—endothelium—systemic scleroderma	0.00243	0.0235	CbGeAlD
Maprotiline—HTR2A—blood vessel—systemic scleroderma	0.00224	0.0217	CbGeAlD
Maprotiline—HTR7—connective tissue—systemic scleroderma	0.00185	0.0178	CbGeAlD
Maprotiline—CHRM3—smooth muscle tissue—systemic scleroderma	0.00177	0.0171	CbGeAlD
Maprotiline—HTR7—smooth muscle tissue—systemic scleroderma	0.00169	0.0163	CbGeAlD
Maprotiline—ORM1—lung—systemic scleroderma	0.00154	0.0149	CbGeAlD
Maprotiline—ABCB1—blood vessel—systemic scleroderma	0.00147	0.0142	CbGeAlD
Maprotiline—SLC6A3—lung—systemic scleroderma	0.00143	0.0138	CbGeAlD
Maprotiline—CHRM3—digestive system—systemic scleroderma	0.0014	0.0135	CbGeAlD
Maprotiline—HRH1—connective tissue—systemic scleroderma	0.00138	0.0133	CbGeAlD
Maprotiline—HTR7—digestive system—systemic scleroderma	0.00133	0.0129	CbGeAlD
Maprotiline—CHRM1—lung—systemic scleroderma	0.00131	0.0126	CbGeAlD
Maprotiline—HTR7—tendon—systemic scleroderma	0.00127	0.0122	CbGeAlD
Maprotiline—HRH1—smooth muscle tissue—systemic scleroderma	0.00126	0.0122	CbGeAlD
Maprotiline—SLC6A2—lung—systemic scleroderma	0.00115	0.0111	CbGeAlD
Maprotiline—HTR2A—connective tissue—systemic scleroderma	0.00115	0.0111	CbGeAlD
Maprotiline—HTR7—lung—systemic scleroderma	0.00111	0.0107	CbGeAlD
Maprotiline—CYP1A2—digestive system—systemic scleroderma	0.00106	0.0103	CbGeAlD
Maprotiline—HTR2A—smooth muscle tissue—systemic scleroderma	0.00105	0.0102	CbGeAlD
Maprotiline—DRD2—lung—systemic scleroderma	0.00105	0.0102	CbGeAlD
Maprotiline—HRH1—digestive system—systemic scleroderma	0.000995	0.0096	CbGeAlD
Maprotiline—HRH1—tendon—systemic scleroderma	0.000947	0.00914	CbGeAlD
Maprotiline—CYP1A2—lung—systemic scleroderma	0.000888	0.00857	CbGeAlD
Maprotiline—HTR2A—digestive system—systemic scleroderma	0.000831	0.00802	CbGeAlD
Maprotiline—HRH1—lung—systemic scleroderma	0.000831	0.00802	CbGeAlD
Maprotiline—HTR2A—tendon—systemic scleroderma	0.000791	0.00763	CbGeAlD
Maprotiline—CYP2D6—digestive system—systemic scleroderma	0.000757	0.00731	CbGeAlD
Maprotiline—HTR2A—lung—systemic scleroderma	0.000694	0.0067	CbGeAlD
Maprotiline—ABCB1—digestive system—systemic scleroderma	0.000545	0.00526	CbGeAlD
Maprotiline—Insomnia—Leflunomide—systemic scleroderma	0.000492	0.00112	CcSEcCtD
Maprotiline—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000492	0.00112	CcSEcCtD
Maprotiline—Paraesthesia—Leflunomide—systemic scleroderma	0.000489	0.00112	CcSEcCtD
Maprotiline—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000488	0.00111	CcSEcCtD
Maprotiline—Anxiety—Lisinopril—systemic scleroderma	0.000486	0.00111	CcSEcCtD
Maprotiline—Hypotension—Mycophenolic acid—systemic scleroderma	0.000485	0.00111	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000485	0.00111	CcSEcCtD
Maprotiline—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000482	0.0011	CcSEcCtD
Maprotiline—Dyspepsia—Leflunomide—systemic scleroderma	0.000479	0.00109	CcSEcCtD
Maprotiline—Vomiting—Mometasone—systemic scleroderma	0.000478	0.00109	CcSEcCtD
Maprotiline—Dry mouth—Lisinopril—systemic scleroderma	0.000477	0.00109	CcSEcCtD
Maprotiline—Sweating increased—Prednisone—systemic scleroderma	0.000476	0.00109	CcSEcCtD
Maprotiline—Feeling abnormal—Azathioprine—systemic scleroderma	0.000475	0.00108	CcSEcCtD
Maprotiline—Rash—Mometasone—systemic scleroderma	0.000474	0.00108	CcSEcCtD
Maprotiline—Asthenia—Captopril—systemic scleroderma	0.000474	0.00108	CcSEcCtD
Maprotiline—Dermatitis—Mometasone—systemic scleroderma	0.000474	0.00108	CcSEcCtD
Maprotiline—Osteoarthritis—Methotrexate—systemic scleroderma	0.000472	0.00108	CcSEcCtD
Maprotiline—Confusional state—Lisinopril—systemic scleroderma	0.000472	0.00108	CcSEcCtD
Maprotiline—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000471	0.00108	CcSEcCtD
Maprotiline—Headache—Mometasone—systemic scleroderma	0.000471	0.00108	CcSEcCtD
Maprotiline—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00047	0.00107	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00047	0.00107	CcSEcCtD
Maprotiline—Insomnia—Mycophenolic acid—systemic scleroderma	0.00047	0.00107	CcSEcCtD
Maprotiline—Fatigue—Leflunomide—systemic scleroderma	0.000469	0.00107	CcSEcCtD
Maprotiline—Oedema—Lisinopril—systemic scleroderma	0.000468	0.00107	CcSEcCtD
Maprotiline—Pruritus—Captopril—systemic scleroderma	0.000467	0.00107	CcSEcCtD
Maprotiline—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000466	0.00106	CcSEcCtD
Maprotiline—Constipation—Leflunomide—systemic scleroderma	0.000465	0.00106	CcSEcCtD
Maprotiline—Infection—Lisinopril—systemic scleroderma	0.000465	0.00106	CcSEcCtD
Maprotiline—Somnolence—Mycophenolic acid—systemic scleroderma	0.000462	0.00105	CcSEcCtD
Maprotiline—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000461	0.00105	CcSEcCtD
Maprotiline—Shock—Lisinopril—systemic scleroderma	0.00046	0.00105	CcSEcCtD
Maprotiline—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000458	0.00105	CcSEcCtD
Maprotiline—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000457	0.00104	CcSEcCtD
Maprotiline—Tachycardia—Lisinopril—systemic scleroderma	0.000456	0.00104	CcSEcCtD
Maprotiline—Abdominal pain—Azathioprine—systemic scleroderma	0.000456	0.00104	CcSEcCtD
Maprotiline—Body temperature increased—Azathioprine—systemic scleroderma	0.000456	0.00104	CcSEcCtD
Maprotiline—ABCB1—lung—systemic scleroderma	0.000455	0.00439	CbGeAlD
Maprotiline—Skin disorder—Lisinopril—systemic scleroderma	0.000454	0.00104	CcSEcCtD
Maprotiline—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000452	0.00103	CcSEcCtD
Maprotiline—Diarrhoea—Captopril—systemic scleroderma	0.000452	0.00103	CcSEcCtD
Maprotiline—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00045	0.00103	CcSEcCtD
Maprotiline—Erectile dysfunction—Prednisone—systemic scleroderma	0.00045	0.00103	CcSEcCtD
Maprotiline—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000449	0.00103	CcSEcCtD
Maprotiline—Feeling abnormal—Leflunomide—systemic scleroderma	0.000449	0.00102	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000448	0.00102	CcSEcCtD
Maprotiline—Fatigue—Mycophenolic acid—systemic scleroderma	0.000448	0.00102	CcSEcCtD
Maprotiline—Nausea—Mometasone—systemic scleroderma	0.000447	0.00102	CcSEcCtD
Maprotiline—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000445	0.00102	CcSEcCtD
Maprotiline—Weight increased—Prednisone—systemic scleroderma	0.000445	0.00101	CcSEcCtD
Maprotiline—Ataxia—Methotrexate—systemic scleroderma	0.000444	0.00101	CcSEcCtD
Maprotiline—Constipation—Mycophenolic acid—systemic scleroderma	0.000444	0.00101	CcSEcCtD
Maprotiline—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000444	0.00101	CcSEcCtD
Maprotiline—Weight decreased—Prednisone—systemic scleroderma	0.000442	0.00101	CcSEcCtD
Maprotiline—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000441	0.00101	CcSEcCtD
Maprotiline—Hypotension—Lisinopril—systemic scleroderma	0.000437	0.000998	CcSEcCtD
Maprotiline—Dizziness—Captopril—systemic scleroderma	0.000437	0.000997	CcSEcCtD
Maprotiline—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000436	0.000996	CcSEcCtD
Maprotiline—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000993	CcSEcCtD
Maprotiline—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00099	CcSEcCtD
Maprotiline—Urticaria—Leflunomide—systemic scleroderma	0.000432	0.000987	CcSEcCtD
Maprotiline—Body temperature increased—Leflunomide—systemic scleroderma	0.00043	0.000982	CcSEcCtD
Maprotiline—Abdominal pain—Leflunomide—systemic scleroderma	0.00043	0.000982	CcSEcCtD
Maprotiline—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000429	0.00098	CcSEcCtD
Maprotiline—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000428	0.000977	CcSEcCtD
Maprotiline—Myocardial infarction—Prednisone—systemic scleroderma	0.000427	0.000975	CcSEcCtD
Maprotiline—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000427	0.000975	CcSEcCtD
Maprotiline—Breast disorder—Methotrexate—systemic scleroderma	0.000427	0.000975	CcSEcCtD
Maprotiline—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000426	0.000973	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000425	0.000971	CcSEcCtD
Maprotiline—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000425	0.000969	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000425	0.000969	CcSEcCtD
Maprotiline—Insomnia—Lisinopril—systemic scleroderma	0.000423	0.000966	CcSEcCtD
Maprotiline—Paraesthesia—Lisinopril—systemic scleroderma	0.00042	0.000959	CcSEcCtD
Maprotiline—Vomiting—Captopril—systemic scleroderma	0.00042	0.000959	CcSEcCtD
Maprotiline—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000418	0.000955	CcSEcCtD
Maprotiline—Rash—Captopril—systemic scleroderma	0.000416	0.000951	CcSEcCtD
Maprotiline—Dermatitis—Captopril—systemic scleroderma	0.000416	0.00095	CcSEcCtD
Maprotiline—Somnolence—Lisinopril—systemic scleroderma	0.000416	0.000949	CcSEcCtD
Maprotiline—Headache—Captopril—systemic scleroderma	0.000414	0.000945	CcSEcCtD
Maprotiline—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000413	0.000943	CcSEcCtD
Maprotiline—Dyspepsia—Lisinopril—systemic scleroderma	0.000412	0.00094	CcSEcCtD
Maprotiline—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00041	0.000937	CcSEcCtD
Maprotiline—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00041	0.000937	CcSEcCtD
Maprotiline—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00041	0.000936	CcSEcCtD
Maprotiline—Infection—Mycophenolate mofetil—systemic scleroderma	0.000407	0.00093	CcSEcCtD
Maprotiline—Eosinophilia—Methotrexate—systemic scleroderma	0.000404	0.000923	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000404	0.000922	CcSEcCtD
Maprotiline—Fatigue—Lisinopril—systemic scleroderma	0.000403	0.000921	CcSEcCtD
Maprotiline—Shock—Mycophenolate mofetil—systemic scleroderma	0.000403	0.000921	CcSEcCtD
Maprotiline—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000402	0.000918	CcSEcCtD
Maprotiline—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000401	0.000916	CcSEcCtD
Maprotiline—Constipation—Lisinopril—systemic scleroderma	0.0004	0.000913	CcSEcCtD
Maprotiline—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.0004	0.000913	CcSEcCtD
Maprotiline—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000398	0.000909	CcSEcCtD
Maprotiline—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000396	0.000904	CcSEcCtD
Maprotiline—Diarrhoea—Azathioprine—systemic scleroderma	0.000394	0.0009	CcSEcCtD
Maprotiline—Nausea—Captopril—systemic scleroderma	0.000392	0.000896	CcSEcCtD
Maprotiline—Asthenia—Leflunomide—systemic scleroderma	0.000391	0.000892	CcSEcCtD
Maprotiline—Hallucination—Prednisone—systemic scleroderma	0.000389	0.000888	CcSEcCtD
Maprotiline—Pancytopenia—Methotrexate—systemic scleroderma	0.000388	0.000885	CcSEcCtD
Maprotiline—Feeling abnormal—Lisinopril—systemic scleroderma	0.000385	0.00088	CcSEcCtD
Maprotiline—Pruritus—Leflunomide—systemic scleroderma	0.000385	0.000879	CcSEcCtD
Maprotiline—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000383	0.000874	CcSEcCtD
Maprotiline—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000382	0.000873	CcSEcCtD
Maprotiline—Dizziness—Azathioprine—systemic scleroderma	0.000381	0.00087	CcSEcCtD
Maprotiline—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000376	0.000858	CcSEcCtD
Maprotiline—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000373	0.000851	CcSEcCtD
Maprotiline—Asthenia—Mycophenolic acid—systemic scleroderma	0.000373	0.000851	CcSEcCtD
Maprotiline—Diarrhoea—Leflunomide—systemic scleroderma	0.000372	0.00085	CcSEcCtD
Maprotiline—Urticaria—Lisinopril—systemic scleroderma	0.000372	0.000848	CcSEcCtD
Maprotiline—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000371	0.000846	CcSEcCtD
Maprotiline—Abdominal pain—Lisinopril—systemic scleroderma	0.00037	0.000844	CcSEcCtD
Maprotiline—Body temperature increased—Lisinopril—systemic scleroderma	0.00037	0.000844	CcSEcCtD
Maprotiline—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000368	0.00084	CcSEcCtD
Maprotiline—Pruritus—Mycophenolic acid—systemic scleroderma	0.000367	0.000839	CcSEcCtD
Maprotiline—Vomiting—Azathioprine—systemic scleroderma	0.000366	0.000837	CcSEcCtD
Maprotiline—Eye disorder—Prednisone—systemic scleroderma	0.000365	0.000834	CcSEcCtD
Maprotiline—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000364	0.000832	CcSEcCtD
Maprotiline—Drowsiness—Methotrexate—systemic scleroderma	0.000364	0.000831	CcSEcCtD
Maprotiline—Infestation NOS—Methotrexate—systemic scleroderma	0.000364	0.000831	CcSEcCtD
Maprotiline—Infestation—Methotrexate—systemic scleroderma	0.000364	0.000831	CcSEcCtD
Maprotiline—Rash—Azathioprine—systemic scleroderma	0.000363	0.00083	CcSEcCtD
Maprotiline—Dermatitis—Azathioprine—systemic scleroderma	0.000363	0.000829	CcSEcCtD
Maprotiline—Flushing—Prednisone—systemic scleroderma	0.000363	0.000828	CcSEcCtD
Maprotiline—Headache—Azathioprine—systemic scleroderma	0.000361	0.000824	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000361	0.000824	CcSEcCtD
Maprotiline—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000824	CcSEcCtD
Maprotiline—Dizziness—Leflunomide—systemic scleroderma	0.00036	0.000822	CcSEcCtD
Maprotiline—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000355	0.000811	CcSEcCtD
Maprotiline—Stomatitis—Methotrexate—systemic scleroderma	0.000355	0.00081	CcSEcCtD
Maprotiline—Angiopathy—Prednisone—systemic scleroderma	0.000355	0.00081	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000808	CcSEcCtD
Maprotiline—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00035	0.0008	CcSEcCtD
Maprotiline—Arrhythmia—Prednisone—systemic scleroderma	0.000349	0.000797	CcSEcCtD
Maprotiline—Vomiting—Leflunomide—systemic scleroderma	0.000346	0.00079	CcSEcCtD
Maprotiline—Alopecia—Prednisone—systemic scleroderma	0.000345	0.000789	CcSEcCtD
Maprotiline—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000344	0.000786	CcSEcCtD
Maprotiline—Dizziness—Mycophenolic acid—systemic scleroderma	0.000343	0.000784	CcSEcCtD
Maprotiline—Rash—Leflunomide—systemic scleroderma	0.000343	0.000784	CcSEcCtD
Maprotiline—Dermatitis—Leflunomide—systemic scleroderma	0.000343	0.000783	CcSEcCtD
Maprotiline—Nausea—Azathioprine—systemic scleroderma	0.000342	0.000782	CcSEcCtD
Maprotiline—Headache—Leflunomide—systemic scleroderma	0.000341	0.000779	CcSEcCtD
Maprotiline—Malnutrition—Prednisone—systemic scleroderma	0.00034	0.000777	CcSEcCtD
Maprotiline—Agranulocytosis—Methotrexate—systemic scleroderma	0.00034	0.000776	CcSEcCtD
Maprotiline—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000338	0.000771	CcSEcCtD
Maprotiline—Asthenia—Lisinopril—systemic scleroderma	0.000336	0.000766	CcSEcCtD
Maprotiline—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000335	0.000765	CcSEcCtD
Maprotiline—Pruritus—Lisinopril—systemic scleroderma	0.000331	0.000755	CcSEcCtD
Maprotiline—Vomiting—Mycophenolic acid—systemic scleroderma	0.00033	0.000754	CcSEcCtD
Maprotiline—Rash—Mycophenolic acid—systemic scleroderma	0.000327	0.000748	CcSEcCtD
Maprotiline—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000327	0.000747	CcSEcCtD
Maprotiline—Hepatitis—Methotrexate—systemic scleroderma	0.000327	0.000746	CcSEcCtD
Maprotiline—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000326	0.000743	CcSEcCtD
Maprotiline—Headache—Mycophenolic acid—systemic scleroderma	0.000325	0.000743	CcSEcCtD
Maprotiline—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000324	0.00074	CcSEcCtD
Maprotiline—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000324	0.00074	CcSEcCtD
Maprotiline—Nausea—Leflunomide—systemic scleroderma	0.000323	0.000738	CcSEcCtD
Maprotiline—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000323	0.000737	CcSEcCtD
Maprotiline—Vision blurred—Prednisone—systemic scleroderma	0.000321	0.000732	CcSEcCtD
Maprotiline—Urethral disorder—Methotrexate—systemic scleroderma	0.00032	0.000731	CcSEcCtD
Maprotiline—Diarrhoea—Lisinopril—systemic scleroderma	0.00032	0.000731	CcSEcCtD
Maprotiline—Agitation—Prednisone—systemic scleroderma	0.000313	0.000714	CcSEcCtD
Maprotiline—Dizziness—Lisinopril—systemic scleroderma	0.000309	0.000706	CcSEcCtD
Maprotiline—Erythema multiforme—Methotrexate—systemic scleroderma	0.000309	0.000705	CcSEcCtD
Maprotiline—Nausea—Mycophenolic acid—systemic scleroderma	0.000308	0.000704	CcSEcCtD
Maprotiline—Eye disorder—Methotrexate—systemic scleroderma	0.000305	0.000697	CcSEcCtD
Maprotiline—Syncope—Prednisone—systemic scleroderma	0.000305	0.000697	CcSEcCtD
Maprotiline—Tinnitus—Methotrexate—systemic scleroderma	0.000305	0.000696	CcSEcCtD
Maprotiline—Cardiac disorder—Methotrexate—systemic scleroderma	0.000303	0.000692	CcSEcCtD
Maprotiline—Loss of consciousness—Prednisone—systemic scleroderma	0.000299	0.000683	CcSEcCtD
Maprotiline—Vomiting—Lisinopril—systemic scleroderma	0.000297	0.000679	CcSEcCtD
Maprotiline—Angiopathy—Methotrexate—systemic scleroderma	0.000296	0.000677	CcSEcCtD
Maprotiline—Rash—Lisinopril—systemic scleroderma	0.000295	0.000673	CcSEcCtD
Maprotiline—Convulsion—Prednisone—systemic scleroderma	0.000295	0.000673	CcSEcCtD
Maprotiline—Dermatitis—Lisinopril—systemic scleroderma	0.000295	0.000673	CcSEcCtD
Maprotiline—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000294	0.000672	CcSEcCtD
Maprotiline—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000294	0.000671	CcSEcCtD
Maprotiline—Hypertension—Prednisone—systemic scleroderma	0.000294	0.000671	CcSEcCtD
Maprotiline—Headache—Lisinopril—systemic scleroderma	0.000293	0.000669	CcSEcCtD
Maprotiline—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00029	0.000662	CcSEcCtD
Maprotiline—Anxiety—Prednisone—systemic scleroderma	0.000289	0.000659	CcSEcCtD
Maprotiline—Alopecia—Methotrexate—systemic scleroderma	0.000289	0.000659	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000288	0.000657	CcSEcCtD
Maprotiline—Malnutrition—Methotrexate—systemic scleroderma	0.000284	0.000649	CcSEcCtD
Maprotiline—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00028	0.00064	CcSEcCtD
Maprotiline—Dysgeusia—Methotrexate—systemic scleroderma	0.000279	0.000636	CcSEcCtD
Maprotiline—Nausea—Lisinopril—systemic scleroderma	0.000278	0.000634	CcSEcCtD
Maprotiline—Oedema—Prednisone—systemic scleroderma	0.000278	0.000634	CcSEcCtD
Maprotiline—Infection—Prednisone—systemic scleroderma	0.000276	0.00063	CcSEcCtD
Maprotiline—Shock—Prednisone—systemic scleroderma	0.000273	0.000624	CcSEcCtD
Maprotiline—Nervous system disorder—Prednisone—systemic scleroderma	0.000272	0.000622	CcSEcCtD
Maprotiline—Tachycardia—Prednisone—systemic scleroderma	0.000271	0.000619	CcSEcCtD
Maprotiline—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000271	0.000619	CcSEcCtD
Maprotiline—Skin disorder—Prednisone—systemic scleroderma	0.00027	0.000616	CcSEcCtD
Maprotiline—Hyperhidrosis—Prednisone—systemic scleroderma	0.000269	0.000613	CcSEcCtD
Maprotiline—Vision blurred—Methotrexate—systemic scleroderma	0.000268	0.000612	CcSEcCtD
Maprotiline—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000595	CcSEcCtD
Maprotiline—Rash—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00059	CcSEcCtD
Maprotiline—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000258	0.000589	CcSEcCtD
Maprotiline—Headache—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000586	CcSEcCtD
Maprotiline—Leukopenia—Methotrexate—systemic scleroderma	0.000255	0.000581	CcSEcCtD
Maprotiline—Insomnia—Prednisone—systemic scleroderma	0.000251	0.000574	CcSEcCtD
Maprotiline—Paraesthesia—Prednisone—systemic scleroderma	0.000249	0.000569	CcSEcCtD
Maprotiline—Convulsion—Methotrexate—systemic scleroderma	0.000246	0.000563	CcSEcCtD
Maprotiline—Dyspepsia—Prednisone—systemic scleroderma	0.000245	0.000558	CcSEcCtD
Maprotiline—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000556	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00024	0.000549	CcSEcCtD
Maprotiline—Fatigue—Prednisone—systemic scleroderma	0.000239	0.000547	CcSEcCtD
Maprotiline—Constipation—Prednisone—systemic scleroderma	0.000238	0.000542	CcSEcCtD
Maprotiline—Confusional state—Methotrexate—systemic scleroderma	0.000234	0.000534	CcSEcCtD
Maprotiline—Infection—Methotrexate—systemic scleroderma	0.000231	0.000527	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisone—systemic scleroderma	0.000229	0.000523	CcSEcCtD
Maprotiline—Nervous system disorder—Methotrexate—systemic scleroderma	0.000228	0.00052	CcSEcCtD
Maprotiline—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000227	0.000519	CcSEcCtD
Maprotiline—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000227	0.000519	CcSEcCtD
Maprotiline—Skin disorder—Methotrexate—systemic scleroderma	0.000225	0.000515	CcSEcCtD
Maprotiline—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000224	0.000512	CcSEcCtD
Maprotiline—Urticaria—Prednisone—systemic scleroderma	0.000221	0.000504	CcSEcCtD
Maprotiline—Body temperature increased—Prednisone—systemic scleroderma	0.00022	0.000501	CcSEcCtD
Maprotiline—Abdominal pain—Prednisone—systemic scleroderma	0.00022	0.000501	CcSEcCtD
Maprotiline—Hypotension—Methotrexate—systemic scleroderma	0.000217	0.000495	CcSEcCtD
Maprotiline—Insomnia—Methotrexate—systemic scleroderma	0.00021	0.000479	CcSEcCtD
Maprotiline—Paraesthesia—Methotrexate—systemic scleroderma	0.000208	0.000476	CcSEcCtD
Maprotiline—Somnolence—Methotrexate—systemic scleroderma	0.000206	0.000471	CcSEcCtD
Maprotiline—Dyspepsia—Methotrexate—systemic scleroderma	0.000204	0.000467	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.0002	0.000458	CcSEcCtD
Maprotiline—Fatigue—Methotrexate—systemic scleroderma	0.0002	0.000457	CcSEcCtD
Maprotiline—Asthenia—Prednisone—systemic scleroderma	0.000199	0.000455	CcSEcCtD
Maprotiline—Pruritus—Prednisone—systemic scleroderma	0.000197	0.000449	CcSEcCtD
Maprotiline—Feeling abnormal—Methotrexate—systemic scleroderma	0.000191	0.000437	CcSEcCtD
Maprotiline—Diarrhoea—Prednisone—systemic scleroderma	0.00019	0.000434	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00019	0.000433	CcSEcCtD
Maprotiline—Urticaria—Methotrexate—systemic scleroderma	0.000184	0.000421	CcSEcCtD
Maprotiline—Dizziness—Prednisone—systemic scleroderma	0.000184	0.000419	CcSEcCtD
Maprotiline—Abdominal pain—Methotrexate—systemic scleroderma	0.000184	0.000419	CcSEcCtD
Maprotiline—Body temperature increased—Methotrexate—systemic scleroderma	0.000184	0.000419	CcSEcCtD
Maprotiline—Vomiting—Prednisone—systemic scleroderma	0.000177	0.000403	CcSEcCtD
Maprotiline—Rash—Prednisone—systemic scleroderma	0.000175	0.0004	CcSEcCtD
Maprotiline—Dermatitis—Prednisone—systemic scleroderma	0.000175	0.0004	CcSEcCtD
Maprotiline—Headache—Prednisone—systemic scleroderma	0.000174	0.000397	CcSEcCtD
Maprotiline—Asthenia—Methotrexate—systemic scleroderma	0.000167	0.00038	CcSEcCtD
Maprotiline—Nausea—Prednisone—systemic scleroderma	0.000165	0.000377	CcSEcCtD
Maprotiline—Pruritus—Methotrexate—systemic scleroderma	0.000164	0.000375	CcSEcCtD
Maprotiline—Diarrhoea—Methotrexate—systemic scleroderma	0.000159	0.000363	CcSEcCtD
Maprotiline—Dizziness—Methotrexate—systemic scleroderma	0.000154	0.00035	CcSEcCtD
Maprotiline—Vomiting—Methotrexate—systemic scleroderma	0.000148	0.000337	CcSEcCtD
Maprotiline—Rash—Methotrexate—systemic scleroderma	0.000146	0.000334	CcSEcCtD
Maprotiline—Dermatitis—Methotrexate—systemic scleroderma	0.000146	0.000334	CcSEcCtD
Maprotiline—Headache—Methotrexate—systemic scleroderma	0.000145	0.000332	CcSEcCtD
Maprotiline—Nausea—Methotrexate—systemic scleroderma	0.000138	0.000315	CcSEcCtD
